Weltz Tim K, Skautrup Signe M, Snog Maria O, Wulff Ida K K, Larsen Andreas, Hemmingsen Mathilde N, Jensen Lisa T, Andersen Pia C L, Uth Charlotte C, Bredgaard Rikke, Hölmich Lisbet R, Krezdorn Nicco, Vester-Glowinski Peter, Ørholt Mathias, Herly Mikkel
Department of Plastic Surgery and Burns Treatment, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Plastic and Reconstructive Surgery, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, Denmark.
J Plast Reconstr Aesthet Surg. 2025 May;104:426-433. doi: 10.1016/j.bjps.2025.02.046. Epub 2025 Feb 25.
High body mass index (BMI) has been linked to higher risk of complications following implant-based breast reconstruction. However, the impact of increasing BMI within the normal to overweight range (18.5-30 kg/m) remains underexplored. We aimed to examine the association between BMI and complications and evaluate differences in risk of implant loss between patients undergoing immediate- and delayed reconstruction.
Consecutive patients who underwent implant-based breast reconstruction from 2010-2023 at three plastic surgical departments were analyzed with BMI as a continuous variable. The primary outcome was implant loss stratified by immediate versus delayed reconstruction. Secondary outcomes included implant infection, seroma, hematoma, and mastectomy skin flap necrosis. All outcomes were analyzed with multivariate Cox regression.
We included 1847 patients (2631 breasts) with a median BMI of 23.3 kg/m (IQR 21.0-25.8, range 17.1-36.9). In patients undergoing immediate reconstruction, BMI was significantly associated with an increased risk of implant loss (P=0.04) but not after delayed reconstruction (P=0.22). Overall, higher BMI was significantly associated with risk of implant infection (P=0.003) and seroma (P<0.001) but not hematoma or mastectomy skin flap necrosis. The absolute risk difference for implant loss between BMI 23 kg/m² (6.2%) and 30 kg/m² (8.2%) was 2.0% (95% CI -2.9 to 6.8) for immediate reconstruction.
The small absolute risk differences for complications in patients with BMI between 23 and 30 kg/m² suggest that patients with BMI ≤30 kg/m² should not be discouraged from implant-based breast reconstruction. However, delayed reconstruction may be a safer option for patients with higher BMI.
高体重指数(BMI)与植入式乳房重建术后并发症风险增加有关。然而,BMI在正常至超重范围(18.5-30kg/m²)内升高的影响仍未得到充分研究。我们旨在研究BMI与并发症之间的关联,并评估即刻重建和延迟重建患者植入物丢失风险的差异。
对2010年至2023年在三个整形外科科室接受植入式乳房重建的连续患者进行分析,将BMI作为连续变量。主要结局是按即刻重建与延迟重建分层的植入物丢失。次要结局包括植入物感染、血清肿、血肿和乳房切除皮瓣坏死。所有结局均采用多变量Cox回归分析。
我们纳入了1847例患者(2631个乳房),中位BMI为23.3kg/m²(IQR 21.0-25.8,范围17.1-36.9)。在接受即刻重建的患者中,BMI与植入物丢失风险增加显著相关(P=0.04),但在延迟重建后则不然(P=0.22)。总体而言,较高的BMI与植入物感染风险(P=0.003)和血清肿风险(P<0.001)显著相关,但与血肿或乳房切除皮瓣坏死无关。对于即刻重建,BMI为23kg/m²(6.2%)和30kg/m²(8.2%)的患者之间植入物丢失的绝对风险差异为2.0%(95%CI -2.9至6.8)。
BMI在23至30kg/m²之间的患者并发症绝对风险差异较小,这表明BMI≤30kg/m²的患者不应因植入式乳房重建而气馁。然而,对于BMI较高的患者,延迟重建可能是更安全的选择。